None
Conditions
Interventions
None
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: - Mentally competent - Age between 18 and 35 years old - Non-smokers - For trans men: only individuals using Androgel at the start of the study - Last visit to the dentist 1 year ago or less
Exclusion criteria
Exclusion criteria: - Evidence of any systemic disease or compromised health condition - Medication use (on a daily basis, other than medication for the purpose of GAHT) - Use of antibiotics during the last 2 months - Use of antifungals during the last 2 months - Need of antibiotic prophylaxis prior to dental treatment - The use of anti-inflammatory drugs on a regular basis - Long-term prescribed medication - Active periodontal disease: pockets = 5mm and/or more than 50% of bleeding sites assessed by bleeding on probing (BOP) - Overt caries
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary aim of this study is to determine the effects of GAHT on the oral health status of the participants undergoing GAHT therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives include the assessment of periodontal status, assessment of clinical changes by means of QLF technology, assessment of levels of hormones in saliva, assessment of the microbiological/mycobiological changes secondary to the hormonal therapy and assessment of the self-perception of the participants regarding their oral status. | — |
Contacts
Public ContactPilar Cornejo
ACTA
Outcome results
None listed